Visit the HL7 website
Visit the FHIR website

CA Core+ 1.0.0 DFT-preBallot

1.0.0-DFT-preBallot   Canada flag
  • Home
  • Business Context
    • Business Context
    • Relationship to PCHDCF
    • Relationship to Other Specifications
    • CA Core+ to pCHDCF Mapping
  • Technical Context
    • Technical Context
    • Artifact Status Summary
    • Profiling Conventions & Approach
    • General Guidance
    • Mapping Logic
    • Security And Privacy
  • Modules
    • Modules
    • Common Data Exchange
    • Workflows
  • FHIR Artifacts
    • FHIR Artifacts
    • Profiles
    • Extensions
    • Data Types
    • Terminology
    • Examples
    • Download
  • Change Log
    • Change Log
    • Specification Guidance
    • Copyrights
    • Known Issues & Future Development
    • Specification Feedback
    1. Home
    2. FHIR Artifacts
    3. Terminology
    4. TherapeuticMoietyTM

Draft preBallot - This specification is under preBallot review and subject to change. It should not be used for implementation purposes. . . . . For a full list of available versions, see the Directory of published versions

TherapeuticMoietyTM

Link to ValueSet

This link will take you to this ValueSet on Simplifier.

therapeuticmoietytm

Canonical URL

https://fhir.infoway-inforoute.ca/ValueSet/therapeuticmoietytm

Resource content

The views below provide an HTML rendered, XML and JSON look at this ValueSet:

  • Overview
  • XML
  • JSON

ValueSet 'TherapeuticMoietyTM'

Published byCanada Health Infoway
StatusDraft (since 2025-03-31)
ExperimentalFalse

The representation of the functional and clinically significant part of the active ingredient substance(s) present in a medicinal product, and as such the TM class is an abstract representation of a medicinal product without reference to strength and dose form, focusing only on active ingredient substance(s). This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset is part of the Canadian Clinical Drug Data Set maintained by Health Canada. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server.

Contact Information

Website: http://www.infoway-inforoute.c...
Email: standards@infoway-inforoute.ca

This value set includes codes from the following code systems:

  • Include codes from CCDD where ccddtype In TM
<ValueSet xmlns="http://hl7.org/fhir">
    <id value="therapeuticmoietytm" />
    <url value="https://fhir.infoway-inforoute.ca/ValueSet/therapeuticmoietytm" />
    <name value="TherapeuticMoietyTM" />
    <title value="Therapeutic Moiety TM" />
    <status value="draft" />
    <experimental value="false" />
    <date value="2025-03-31" />
    <publisher value="Canada Health Infoway" />
    <contact>
        <telecom>
            <system value="url" />
            <value value="http://www.infoway-inforoute.ca" />
        </telecom>
        <telecom>
            <system value="email" />
            <value value="standards@infoway-inforoute.ca" />
        </telecom>
    </contact>
    <description value="The representation of the functional and clinically significant part of the active ingredient substance(s) present in a medicinal product, and as such the TM class is an abstract representation of a medicinal product without reference to strength and dose form, focusing only on active ingredient substance(s). This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset is part of the Canadian Clinical Drug Data Set maintained by Health Canada. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway&#39;s [Terminology Server](https://infocentral.infoway-inforoute.ca/en/tools/standards-tools/terminology-server)." />
    <jurisdiction>
        <coding>
            <system value="urn:iso:std:iso:3166" />
            <code value="CA" />
        </coding>
    </jurisdiction>
    <copyright value="Copyright &#169; 2025+ Canada Health Infoway. All rights reserved. [Terms of Use and License Agreements](https://ic.infoway-inforoute.ca/en/about/tou). [Privacy Policy](https://www.infoway-inforoute.ca/en/legal/privacy-policy)." />
    <compose>
        <include>
            <system value="http://terminology.hl7.org/CodeSystem/hc-CCDD" />
            <filter>
                <property value="ccddtype" />
                <op value="in" />
                <value value="TM" />
            </filter>
        </include>
    </compose>
</ValueSet>
{
    "resourceType": "ValueSet",
    "id": "therapeuticmoietytm",
    "url": "https://fhir.infoway-inforoute.ca/ValueSet/therapeuticmoietytm",
    "name": "TherapeuticMoietyTM",
    "title": "Therapeutic Moiety TM",
    "status": "draft",
    "experimental": false,
    "date": "2025-03-31",
    "publisher": "Canada Health Infoway",
    "contact":  [
        {
            "telecom":  [
                {
                    "system": "url",
                    "value": "http://www.infoway-inforoute.ca"
                },
                {
                    "system": "email",
                    "value": "standards@infoway-inforoute.ca"
                }
            ]
        }
    ],
    "description": "The representation of the functional and clinically significant part of the active ingredient substance(s) present in a medicinal product, and as such the TM class is an abstract representation of a medicinal product without reference to strength and dose form, focusing only on active ingredient substance(s). This is a broad data exchange subset that is intended to support semantic interoperability and conformance testing. It is recommended that jurisdictions define and implement more specific clinically curated subsets that contain a portion of these concepts for data capture at the point of care for their specific use case. This subset is part of the Canadian Clinical Drug Data Set maintained by Health Canada. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's [Terminology Server](https://infocentral.infoway-inforoute.ca/en/tools/standards-tools/terminology-server).",
    "jurisdiction":  [
        {
            "coding":  [
                {
                    "system": "urn:iso:std:iso:3166",
                    "code": "CA"
                }
            ]
        }
    ],
    "copyright": "Copyright © 2025+ Canada Health Infoway. All rights reserved. [Terms of Use and License Agreements](https://ic.infoway-inforoute.ca/en/about/tou). [Privacy Policy](https://www.infoway-inforoute.ca/en/legal/privacy-policy).",
    "compose": {
        "include":  [
            {
                "system": "http://terminology.hl7.org/CodeSystem/hc-CCDD",
                "filter":  [
                    {
                        "property": "ccddtype",
                        "op": "in",
                        "value": "TM"
                    }
                ]
            }
        ]
    }
}

Table of Contents | IG © based on FHIR R4 | Package package:ca.infoway.io.core@1.0.0-dft-preballot | Version History
HL7® and FHIR® are the registered trademarks of Health Level Seven International